EVH — Evolent Health, Inc.

NYSE · Unknown · Unknown · CIK 1628908 ·
Last close
$3.83
Market Cap
$430.80M
52W High
$4.53
52W Low
$2.10
ADV30
2,642,693
Next earnings
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 496,246,000 83,774,000 -10,599,000 -26,632,000 1,878,847,000 142,028,000 1,482,454,000
Dec 2025 468,719,000 97,253,000 -20,440,000 -429,131,000 1,899,236,000 151,856,000 1,484,042,000
Sep 2025 479,533,000 99,774,000 -1,433,000 -20,864,000 2,453,459,000 116,650,000 1,611,226,000
Jun 2025 444,328,000 100,385,000 2,035,000 -19,897,000 2,461,532,000 150,995,000 1,565,527,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$38,843,000
Investing CF
$-91,545,000
Financing CF
$-35,924,000
CapEx
$-34,088,000
Dividends Paid
$-11,127,000
Buybacks
$0
EPS Diluted TTM
$-5.15
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,315,327,000
Inventory
Receivables
$309,861,000
ST Investments
EBIT TTM
$-476,011,000
Pretax Income TTM
$-534,636,000
Interest Exp TTM
$58,625,000
Analysts
14

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,888,825,984
EBITDA
$74,355,000
Free Cash Flow
$52,930,624
Enterprise Value
$1,274,199,424
Total Cash
$142,028,000
Total Debt
$985,425,024
Shares Out
112,481,067
Trailing EPS
$-4.68
Book Value
$3.52
ROE
-65.1%
ROA
-0.4%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 1,876,229,000 -19,834,000 -534,510,000 1,899,236,000 1,484,042,000 38,843,000
Dec 2024 2,554,741,000 -14,067,000 -61,623,000 2,544,411,000 1,543,152,000 18,765,000
Dec 2023 1,963,896,000 -21,055,000 -113,040,000 2,680,308,000 1,612,607,000 142,582,000
Dec 2022 1,352,013,000 -19,880,000 -19,164,000 1,817,293,000 957,876,000 -11,553,000

TTM Snapshot

Revenues TTM
$1,707,472,000
NetIncome TTM
$-59,378,000
OpCashFlow TTM
$0
Assets (Latest)
$2,544,411,000
Forward EPS
$0.40

News headlines (Yahoo Finance, 1h cache)

3 Russell 2000 Stocks We’re Skeptical Of
2026-05-23 16:28 · Yahoo
Agentic AI Powers U.S. Healthcare Stocks
2026-05-18 00:19 · Yahoo
Rosarium Health Raises $6M In Seed Funding Round To Provide Reliable And Faster In-Home Care For Aging Populations
2026-05-12 14:41 · Yahoo
3 Small-Cap Stocks We Find Risky
2026-05-12 13:08 · Yahoo
Quest Analytics Expands Leadership Team with Appointment of Chris Lance as Chief Product Officer
2026-05-12 11:00 · Yahoo
Evolent Health Q1 Earnings Call Highlights
2026-05-10 09:12 · Yahoo
Evolent (EVH) Q1 2026 Earnings Call Transcript
2026-05-08 15:54 · Yahoo
Evolent Health, Inc. Q1 2026 Earnings Call Summary
2026-05-08 12:30 · Yahoo
Compared to Estimates, Evolent Health (EVH) Q1 Earnings: A Look at Key Metrics
2026-05-07 13:30 · Yahoo
Evolent Health (EVH) Reports Q1 Loss, Misses Revenue Estimates
2026-05-07 12:50 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.